BLATT LAWRENCE

13D and 13G Filings

13D/G filings
13D on 1 security
CIK
0001242110
All SEC filings
View on sec.gov
Issuer % of Class Filed
Aligos Therapeutics, Inc. 13D
ALGS · 01626L204
5.6% 6/24/2026
Event 6/16/2026
Aligos Therapeutics, Inc. 13G
ALGS · 01626L204
5.1% 5/15/2026
Event 3/31/2026
Aligos Therapeutics, Inc. 13D/A Amendment 1
ALGS · 01626L204
3.2% 3/12/2025
Event 3/10/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.